BioMarin
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
BMRN Key Statistics
Stock Snapshot
As of today, BioMarin(BMRN) shares are valued at $55.03. The company's market cap stands at 10.57B, with a P/E ratio of 20.96.
On 2025-12-01, BioMarin(BMRN) stock moved within a range of $54.95 to $56.09. With shares now at $55.03, the stock is trading +0.1% above its intraday low and -1.9% below the session's peak.
Trading volume for BioMarin(BMRN) stock has reached 2.34M, versus its average volume of 3.81M.
Over the past 52 weeks, BioMarin(BMRN) stock has traded between a high of $73.51 and a low of $50.76.
Over the past 52 weeks, BioMarin(BMRN) stock has traded between a high of $73.51 and a low of $50.76.
BMRN News
BioMarin Pharmaceutical recently presented at the Jefferies London Healthcare Conference 2025 in London, following its announcement of a 4.1% year-over-year rev...
